OBIOOrchestra BioMed Holdings, Inc.
$5.73+110% 1Y
$5.73
$2.8752 weeks$6.36
What is the market doing?
Good
1 good, 2 without dataIn an uptrend. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendUptrendderived · Oct 8, 2026
In an uptrend, above its rising 50- and 200-day averages. Price is +29% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How OBIO is trading
Orchestra BioMed Holdings, Inc. is +110% over the past year while the S&P 500 is +18%: 92 points ahead of the market.
+110%
1-year return · S&P 500 +18%
- vs 200-day average
- +29%
vs 200-day average · a clear uptrend
- RSI (14)
- 42
RSI (14) · neutral
- Below its 52-week high
- 9.8%
Below its 52-week high
Details›
- Last close2026-10-08
- $5.73
- 1 monthS&P 500 +1.6%
- +5.5%
- 1 yearS&P 500 +18%
- +110%
- 5 yearsS&P 500 +86%
- −42%
- vs 50-day average$5.31
- +7.9%
- 52-week high
- $6.36
- 52-week low
- $2.87
- Annualised volatility
- 81%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $158K
| Year | Return |
|---|---|
| 2026 (year to date) | +38% |
| 2025 | +3.8% |
| 2024 | −56% |
| 2023 | −8.5% |
| 2022 | −0.99% |
| 2021 | −21% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 1 of 6 | −5.0% |
| Feb | 6 | 4 of 6 | +3.1% |
| Mar | 6 | 2 of 6 | +12% |
| Apr | 6 | 1 of 6 | −12% |
| May | 6 | 2 of 6 | +6.4% |
| Jun | 6 | 3 of 6 | −5.3% |
| Jul | 6 | 1 of 6 | −3.7% |
| Aug | 6 | 2 of 6 | +1.9% |
| Sep | 7 | 4 of 7 | +4.3% |
| Oct | 7 | 3 of 7 | +0.55% |
| Nov | 6 | 5 of 6 | +14% |
| Dec | 6 | 4 of 6 | +1.5% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.